APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alectinib

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Alectinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

23 December 2025170 pages

Choose your research edition.

Industry ResearchAlectinib Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Alectinib Industry Growth and Trends Forecast to 203278 pages · $3,450 USDMarket StructureGlobal Alectinib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032170 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alectinib Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Alectinib Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Alectinib market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Alectinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alectinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alectinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Alectinib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Alectinib include Roche and Everest Pharmaceuticals among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alectinib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alectinib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alectinib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alectinib market size, projected growth trends, production technologies, key applications, and end-use industries.

Alectinib Segment by Company

Roche

Everest Pharmaceuticals

Alectinib Segment by Type

150mg*140 Capsules

150mg*26 Capsules

150mg*28 Capsules

20mg*1 Capsule

40mg*1 Capsule

Alectinib Segment by Application

Advanced NSCLC

Recurrent NSCLC

Unresectable NSCLC

Others

Alectinib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alectinib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alectinib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alectinib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alectinib market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Alectinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Alectinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Alectinib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Alectinib Industry Trends Table 2. Alectinib Industry Drivers Table 3. Alectinib Industry Opportunities and Challenges Table 4. Alectinib Industry Restraints Table 5. Global Alectinib Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Alectinib Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Alectinib Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Alectinib Sales Market Share by Manufacturers Table 9. Global Alectinib Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Alectinib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Alectinib Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Alectinib Manufacturers, Product Type & Application Table 13. Global Alectinib Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Alectinib by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 150mg*140 Capsules Table 17. Major Manufacturers of 150mg*26 Capsules Table 18. Major Manufacturers of 150mg*28 Capsules Table 19. Major Manufacturers of 20mg*1 Capsule Table 20. Major Manufacturers of 40mg*1 Capsule Table 21. Global Alectinib Sales by Type 2021 VS 2025 VS 2032 (k units) Table 22. Global Alectinib Sales by Type (2021-2026) & (k units) Table 23. Global Alectinib Sales by Type (2027-2032) & (k units) Table 24. Global Alectinib Sales Market Share by Type (2021-2026) Table 25. Global Alectinib Sales Market Share by Type (2027-2032) Table 26. Global Alectinib Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 27. Global Alectinib Revenue by Type (2021-2026) & (k units) Table 28. Global Alectinib Revenue by Type (2027-2032) & (k units) Table 29. Global Alectinib Revenue Market Share by Type (2021-2026) Table 30. Global Alectinib Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Advanced NSCLC Table 32. Major Manufacturers of Recurrent NSCLC Table 33. Major Manufacturers of Unresectable NSCLC Table 34. Major Manufacturers of Others Table 35. Global Alectinib Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Alectinib Sales by Application (2021-2026) & (k units) Table 37. Global Alectinib Sales by Application (2027-2032) & (k units) Table 38. Global Alectinib Sales Market Share by Application (2021-2026) Table 39. Global Alectinib Sales Market Share by Application (2027-2032) Table 40. Global Alectinib Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Alectinib Revenue by Application (2021-2026) & (k units) Table 42. Global Alectinib Revenue by Application (2027-2032) & (k units) Table 43. Global Alectinib Revenue Market Share by Application (2021-2026) Table 44. Global Alectinib Revenue Market Share by Application (2027-2032) Table 45. Global Alectinib Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Alectinib Sales by Region (2021-2026) & (k units) Table 47. Global Alectinib Sales Market Share by Region (2021-2026) Table 48. Global Alectinib Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Alectinib Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Alectinib Sales by Country (2021-2026) & (k units) Table 52. North America Alectinib Sales by Country (2027-2032) & (k units) Table 53. Europe Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Alectinib Sales by Country (2021-2026) & (k units) Table 55. Europe Alectinib Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Alectinib Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Alectinib Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Alectinib Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Alectinib Sales by Country (2027-2032) & (k units) Table 62. Global Alectinib Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Alectinib Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Alectinib Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Alectinib Revenue Market Share by Region (2021-2026) Table 66. Global Alectinib Revenue Market Share by Region (2027-2032) Table 67. Roche Company Information Table 68. Roche Business Overview Table 69. Roche Alectinib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Roche Alectinib Product Portfolio Table 71. Roche Recent Development Table 72. Everest Pharmaceuticals Company Information Table 73. Everest Pharmaceuticals Business Overview Table 74. Everest Pharmaceuticals Alectinib Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Everest Pharmaceuticals Alectinib Product Portfolio Table 76. Everest Pharmaceuticals Recent Development Table 77. Key Raw Materials Table 78. Raw Materials Key Suppliers Table 79. Alectinib Distributors List Table 80. Alectinib Customers List Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Alectinib Product Image Figure 2. Global Alectinib Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alectinib Market Size (2021-2032) & (US$ Million) Figure 4. Global Alectinib Sales (2021-2032) & (k units) Figure 5. Global Alectinib Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Alectinib Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 150mg*140 Capsules Image Figure 9. 150mg*26 Capsules Image Figure 10. 150mg*28 Capsules Image Figure 11. 20mg*1 Capsule Image Figure 12. 40mg*1 Capsule Image Figure 13. Global Alectinib Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Alectinib Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Alectinib Sales Market Share by Type (2021-2032) Figure 16. Global Alectinib Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 17. Global Alectinib Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Alectinib Revenue Market Share by Type (2021-2032) Figure 19. Advanced NSCLC Image Figure 20. Recurrent NSCLC Image Figure 21. Unresectable NSCLC Image Figure 22. Others Image Figure 23. Global Alectinib Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Alectinib Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Alectinib Sales Market Share by Application (2021-2032) Figure 26. Global Alectinib Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Alectinib Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Alectinib Revenue Market Share by Application (2021-2032) Figure 29. North America Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Alectinib Sales Market Share by Country (2021-2032) Figure 31. U.S. Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Alectinib Sales Market Share by Country (2021-2032) Figure 36. Germany Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Alectinib Sales Market Share by Country (2021-2032) Figure 43. China Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Alectinib Sales Market Share by Country (2021-2032) Figure 51. Brazil Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Alectinib Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Alectinib Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Alectinib Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Alectinib Revenue (2021-2032) & (US$ Million) Figure 62. North America Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Alectinib Revenue (2021-2032) & (US$ Million) Figure 64. Europe Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Alectinib Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Alectinib Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Alectinib Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Alectinib Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • 150mg*140 Capsules
  • 150mg*26 Capsules
  • 150mg*28 Capsules
  • 20mg*1 Capsule
  • 40mg*1 Capsule
Applications
  • Advanced NSCLC
  • Recurrent NSCLC
  • Unresectable NSCLC
  • Others
Companies covered
  • Roche
  • Everest Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Alectinib Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Alectinib Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Alectinib Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Alectinib Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Alectinib Market Dynamics
  1. 2.1 Alectinib Industry Trends
  2. 2.2 Alectinib Industry Drivers
  3. 2.3 Alectinib Industry Opportunities and Challenges
  4. 2.4 Alectinib Industry Restraints
3 Alectinib Market by Manufacturers
  1. 3.1 Global Alectinib Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Alectinib Sales by Manufacturers (2021-2026)
  3. 3.3 Global Alectinib Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Alectinib Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Alectinib Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Alectinib Manufacturers, Product Type & Application
  7. 3.7 Global Alectinib Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Alectinib Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Alectinib Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Alectinib Tier 1, Tier 2, and Tier 3
4 Alectinib Market by Type
  1. 4.1 Alectinib Type Introduction
  2. 4.1.1 150mg*140 Capsules
  3. 4.1.2 150mg*26 Capsules
  4. 4.1.3 150mg*28 Capsules
  5. 4.1.4 20mg*1 Capsule
  6. 4.1.5 40mg*1 Capsule
  7. 4.2 Global Alectinib Sales by Type
  8. 4.2.1 Global Alectinib Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Alectinib Sales by Type (2021-2032)
  10. 4.2.3 Global Alectinib Sales Market Share by Type (2021-2032)
  11. 4.3 Global Alectinib Revenue by Type
  12. 4.3.1 Global Alectinib Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Alectinib Revenue by Type (2021-2032)
  14. 4.3.3 Global Alectinib Revenue Market Share by Type (2021-2032)
5 Alectinib Market by Application
  1. 5.1 Alectinib Application Introduction
  2. 5.1.1 Advanced NSCLC
  3. 5.1.2 Recurrent NSCLC
  4. 5.1.3 Unresectable NSCLC
  5. 5.1.4 Others
  6. 5.2 Global Alectinib Sales by Application
  7. 5.2.1 Global Alectinib Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Alectinib Sales by Application (2021-2032)
  9. 5.2.3 Global Alectinib Sales Market Share by Application (2021-2032)
  10. 5.3 Global Alectinib Revenue by Application
  11. 5.3.1 Global Alectinib Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Alectinib Revenue by Application (2021-2032)
  13. 5.3.3 Global Alectinib Revenue Market Share by Application (2021-2032)
6 Global Alectinib Sales by Region
  1. 6.1 Global Alectinib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alectinib Sales by Region (2021-2032)
  3. 6.2.1 Global Alectinib Sales by Region (2021-2026)
  4. 6.2.2 Global Alectinib Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Alectinib Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Alectinib Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Alectinib Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Alectinib Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Alectinib Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Alectinib Revenue by Region
  1. 7.1 Global Alectinib Revenue by Region
  2. 7.1.1 Global Alectinib Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Alectinib Revenue by Region (2021-2026)
  4. 7.1.3 Global Alectinib Revenue by Region (2027-2032)
  5. 7.1.4 Global Alectinib Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Alectinib Revenue (2021-2032)
  8. 7.2.2 North America Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Alectinib Revenue (2021-2032)
  11. 7.3.2 Europe Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Alectinib Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Alectinib Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Alectinib Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Alectinib Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Roche Alectinib Product Portfolio
  6. 8.1.5 Roche Recent Developments
  7. 8.2 Everest Pharmaceuticals
  8. 8.2.1 Everest Pharmaceuticals Company Information
  9. 8.2.2 Everest Pharmaceuticals Business Overview
  10. 8.2.3 Everest Pharmaceuticals Alectinib Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Everest Pharmaceuticals Alectinib Product Portfolio
  12. 8.2.5 Everest Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alectinib Value Chain Analysis
  2. 9.1.1 Alectinib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alectinib Production Mode & Process
  6. 9.2 Alectinib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alectinib Distributors
  9. 9.2.3 Alectinib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst